ACB
Price
$5.32
Change
-$0.08 (-1.48%)
Updated
Oct 9 closing price
28 days until earnings call
ZOM
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Oct 8 closing price
32 days until earnings call
Ad is loading...

ACB vs ZOM

Header iconACB vs ZOM Comparison
Open Charts ACB vs ZOMBanner chart's image
Aurora Cannabis
Price$5.32
Change-$0.08 (-1.48%)
Volume$432.04K
CapitalizationN/A
Zomedica
Price$0.13
Change-$0.00 (-0.00%)
Volume$3.25M
CapitalizationN/A
View a ticker or compare two or three
ACB vs ZOM Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZOM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACB vs. ZOM commentary
Oct 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a StrongSell and ZOM is a StrongSell.

COMPARISON
Comparison
Oct 10, 2024
Stock price -- (ACB: $5.32 vs. ZOM: $0.13)
Brand notoriety: ACB: Notable vs. ZOM: Not notable
ACB represents the Pharmaceuticals: Other, while ZOM is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ACB: 39% vs. ZOM: 46%
Market capitalization -- ACB: $238.86M vs. ZOM: $137.19M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. ZOM’s [@Medical Specialties] market capitalization is $137.19M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.35B. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileZOM’s FA Score has 1 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • ZOM’s FA Score: 1 green, 4 red.
According to our system of comparison, ZOM is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 3 TA indicator(s) are bullish while ZOM’s TA Score has 6 bullish TA indicator(s).

  • ACB’s TA Score: 3 bullish, 4 bearish.
  • ZOM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ZOM is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -0.93% price change this week, while ZOM (@Medical Specialties) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

ACB is expected to report earnings on Feb 06, 2025.

ZOM is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than ZOM($137M). ACB YTD gains are higher at: 11.718 vs. ZOM (-34.915). ZOM has higher annual earnings (EBITDA): -11.94M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. ZOM (106M). ZOM has less debt than ACB: ZOM (1.75M) vs ACB (103M). ACB has higher revenues than ZOM: ACB (212M) vs ZOM (24M).
ACBZOMACB / ZOM
Capitalization239M137M174%
EBITDA-1.64B-11.94M13,716%
Gain YTD11.718-34.915-34%
P/E RatioN/AN/A-
Revenue212M24M883%
Total Cash149M106M141%
Total Debt103M1.75M5,879%
FUNDAMENTALS RATINGS
ACB vs ZOM: Fundamental Ratings
ACB
ZOM
OUTLOOK RATING
1..100
712
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
6161
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZOM's Valuation (28) in the Pharmaceuticals Major industry is significantly better than the same rating for ACB (94) in the Pharmaceuticals Other industry. This means that ZOM’s stock grew significantly faster than ACB’s over the last 12 months.

ZOM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that ZOM’s stock grew similarly to ACB’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ZOM (95) in the Pharmaceuticals Major industry. This means that ACB’s stock grew similarly to ZOM’s over the last 12 months.

ACB's Price Growth Rating (61) in the Pharmaceuticals Other industry is in the same range as ZOM (61) in the Pharmaceuticals Major industry. This means that ACB’s stock grew similarly to ZOM’s over the last 12 months.

ACB's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ZOM (100) in the Pharmaceuticals Major industry. This means that ACB’s stock grew similarly to ZOM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBZOM
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZOM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

ZOM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZOM has been loosely correlated with SNDL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ZOM jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZOM
1D Price
Change %
ZOM100%
-0.46%
SNDL - ZOM
38%
Loosely correlated
+0.52%
CDNA - ZOM
30%
Poorly correlated
-12.42%
EBS - ZOM
29%
Poorly correlated
-3.15%
ARAY - ZOM
29%
Poorly correlated
-4.35%
BNR - ZOM
28%
Poorly correlated
-4.63%
More